Anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients, study suggests
- Scientists have found that a biologic drug can delay Alzheimer's symptoms in specific patients, marking a significant step in treatment options.
- The study revealed a 50% reduction in risk of symptoms for 22 patients who took gantenerumab for an average of eight years.
- Dr. Eric McDade stated that these results suggest a possibility of delaying Alzheimer's progression.
- Dr. Tara Spires-Jones noted that while results are promising, they do not conclusively prove delayed onset, and some might avoid treatment due to modest benefits.
248 Articles
248 Articles
Early detection of Alzheimer’s may start with simple test — Harvard Gazette
Health Sniffing out signs of trouble Mass General Brigham Communications March 25, 2025 3 min read Researchers develop at-home test to ID those at risk of Alzheimer’s years before symptoms appear When it comes to early detection of cognitive impairment, a new study suggests that the nose knows. Researchers from Harvard-affiliated Mass General Brigham developed olfactory tests — in which participants snif…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage